Teladoc Health Names New Chief Legal Officer as Longtime Executive Exits
Event summary
- Adam Vandervoort, Teladoc Health’s Chief Legal Officer for 11 years, will resign effective November 1, 2026.
- Jonathan Dorfman, currently Senior Vice President of Securities and Corporate Law, will succeed Vandervoort on November 2, 2026.
- Dorfman joined Teladoc Health in 2020 through the Livongo acquisition and has led SEC reporting and corporate governance.
- Vandervoort guided Teladoc through its IPO, pandemic growth, and regulatory changes during his tenure.
The big picture
Teladoc Health’s leadership transition in its legal function comes at a time when the virtual care industry faces evolving regulatory landscapes and increasing scrutiny over corporate governance. The shift from a long-serving executive to an internal successor highlights the company’s focus on continuity and institutional knowledge. Dorfman’s background in SEC compliance and corporate governance suggests a strategic emphasis on maintaining robust regulatory compliance amid industry growth.
What we're watching
- Governance Dynamics
- How Dorfman’s promotion will impact Teladoc’s corporate governance and SEC compliance strategies.
- Regulatory Headwinds
- Whether Dorfman can sustain the regulatory adaptability demonstrated under Vandervoort’s leadership.
- Execution Risk
- The pace at which Dorfman integrates his experience from Livongo and prior roles into Teladoc’s legal framework.
Related topics
